Vaxil Bio's total assets for Q4 2024 were C$733.00K, a decrease of -10.61% from the previous quarter. TSE:VXL total liabilities were C$17.00K for the fiscal quarter, a -79.27% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.